Abstract

Post-acute pancreatitis diabetes mellitus (PPDM-A) is the main component of pancreatic exocrine diabetes mellitus. Timely diagnosis of PPDM-A improves patient outcomes and the mitigation of burdens and costs. We aimed to determine risk factors prospectively and predictors of PPDM-A in China, focusing on giving personalized treatment recommendations. Here, we identify and evaluate the best set of predictors of PPDM-A prospectively using retrospective data from 820 patients with acute pancreatitis at four centers by machine learning approaches. We used the L1 regularized logistic regression model to diagnose early PPDM-A via nine clinical variables identified as the best predictors. The model performed well, obtaining the best AUC = 0.819 and F1 = 0.357 in the test set. We interpreted and personalized the model through nomograms and Shapley values. Our model can accurately predict the occurrence of PPDM-A based on just nine clinical pieces of information and allows for early intervention in potential PPDM-A patients through personalized analysis. Future retrospective and prospective studies with multicentre, large sample populations are needed to assess the actual clinical value of the model.

Details

Title
Machine learning for post-acute pancreatitis diabetes mellitus prediction and personalized treatment recommendations
Author
Zhang, Jun 1 ; Lv, Yingqi 1 ; Hou, Jiaying 2 ; Zhang, Chi 3 ; Yua, Xuelu 4 ; Wang, Yifan 1 ; Yang, Ting 1 ; Su, Xianghui 2 ; Ye, Zheng 5   VIAFID ORCID Logo  ; Li, Ling 5   VIAFID ORCID Logo 

 Southeast University, Department of Endocrinology, Zhongda Hospital, School of Medicine, Nanjing, China (GRID:grid.263826.b) (ISNI:0000 0004 1761 0489); Southeast University, Institute of Glucose and Lipid Metabolism, Nanjing, China (GRID:grid.263826.b) (ISNI:0000 0004 1761 0489) 
 First Affiliated Hospital of Xinjiang Medical University, Department of Endocrinology, Changji Branch, Xinjiang, China (GRID:grid.412631.3) 
 First Affiliated Hospital of Hunan Normal University, Department of Endocrinology, Hunan Provincial People’s Hospital, Changsha, China (GRID:grid.411427.5) (ISNI:0000 0001 0089 3695) 
 Yixing Second People’s Hospital, Department of Endocrinology, Wuxi, China (GRID:grid.411427.5) 
 Southeast University, Department of Endocrinology, Zhongda Hospital, School of Medicine, Nanjing, China (GRID:grid.263826.b) (ISNI:0000 0004 1761 0489); Southeast University, Institute of Glucose and Lipid Metabolism, Nanjing, China (GRID:grid.263826.b) (ISNI:0000 0004 1761 0489); Southeast University, Department of Endocrinology, Zhongda Hospital, School of Medicine, Institute of Pancreas, Nanjing, China (GRID:grid.263826.b) (ISNI:0000 0004 1761 0489) 
Pages
4857
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2790222854
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.